Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities
Net loss	$ (72,092)	$ (106,275)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,158	7,463
Non-cash operating lease cost	3,066	2,865
Stock-based compensation	51,893	3,308
Amortization of deferred contract acquisition costs	1,291	858
Deferred tax benefit	(370)	0
Change in fair value of contingent earnout liability	(84,420)	0
Transaction costs expensed	7,031	0
Other	2,203	1,043
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(26,579)	10,053
Inventories	3,498	(5,975)
Prepaid expenses and other assets	(18,879)	(8,388)
Operating lease liabilities	(2,193)	(2,431)
Accounts payable	10,633	(2,397)
Accrued and other liabilities	16,110	1,569
Deferred revenue	29,715	9,085
Net cash used in operating activities	(109,083)	(70,921)
Cash flows from investing activities
Purchases of property and equipment	(12,064)	(8,913)
Maturities of investments	0	47,014
Cash paid for acquisitions, net of cash acquired	(205,329)	0
Net cash (used in) provided by investing activities	(217,393)	38,101
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	0	95,514
Proceeds from issuance of common stock warrants	0	31,545
Proceeds from the exercise of warrants	118,845	0
Merger and PIPE financing	511,646	0
Payment of deferred transaction costs	0	(513)
Payments of transaction costs related to Merger	(32,468)	0
Payment of tax withholding obligations on settlement of earnout shares	(20,895)	0
Repayment of borrowings	(36,051)	0
Proceeds from exercises of vested and unvested stock options	4,214	2,201
Change in driver funds and amounts due to customers	1,933	0
Net cash provided by financing activities	547,224	128,747
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(748)	13
Net increase in cash, cash equivalents, and restricted cash	220,000	95,940
Cash, cash equivalents, and restricted cash at beginning of period	145,891	73,153
Cash, cash equivalents, and restricted cash at end of period	365,891	169,093
Supplementary cash flow information
Cash paid for interest	346	2,120
Cash paid for taxes	119	145
Supplementary cash flow information on noncash investing and financing activities
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0	60,377
Right-of-use assets obtained in exchange for lease liabilities	4,737	14,212
Deferred transaction costs not yet paid	0	3,385
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	1,939	914
Vesting of early exercised stock options	0	15
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization	615,697	0
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization	66,606	0
Contingent earnout liability recognized upon the closing of the reverse recapitalization	828,180	0
Reclassification of remaining contingent earnout liability upon triggering event	242,640	0
Issuance of common stock in connection with acquisitions	102,057	0
Redeemable convertible preferred stock warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	(9,237)	18,301
Private placement warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ (30,911)	$ 0